Hans Petter Tjeldflaat
Nessuna posizione attualmente
Profilo
Hans Petter Tjeldflaat worked as a Finance Director at Affitech.
AS from 2006 to 2009.
He also worked as an Investment Manager at SND Invest AS and as the Head-Investor Relations at Christiania Bank Og Kreditkasse.
He served as the Chief Financial Officer at Inovio AS, Nykode Therapeutics ASA, Nextera AS, Otivio AS, Nordic Nanovector ASA, and RespiNor AS.
Tjeldflaat graduated from the University of Wisconsin with a graduate degree and also holds a graduate degree from the Norwegian School of Economics & Business Administration.
Precedenti posizioni note di Hans Petter Tjeldflaat
| Società | Posizione | Fine |
|---|---|---|
Affitech AS /Old/
 Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Affitech AS discovers and develops human therapeutic antibodies. It focuses on molecule and cell based antibody discovery. The company was founded by Martin Welschof, Ole Jorgen Marvik, and Michael Braunagel in 1997 and is headquartered in Oslo, Norway. | Direttore Finanziario/CFO | 16/06/2009 |
| Christiania Bank Og Kreditkasse | Contatto Relazioni con gli Investitori | - |
Nextera AS
 Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Direttore Finanziario/CFO | - |
RespiNor AS
 RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Direttore Finanziario/CFO | - |
Otivio AS
 Otivio AS Medical SpecialtiesHealth Technology Otivio AS manufactures non-invasive medical devices. The private company is based in Oslo, Norway. | Direttore Finanziario/CFO | - |
Formazione di Hans Petter Tjeldflaat
| University of Wisconsin | Graduate Degree |
| Norwegian School of Economics & Business Administration | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NYKODE THERAPEUTICS | Health Technology |
| Aziende private | 8 |
|---|---|
| SND Invest AS | Finance |
| Christiania Bank Og Kreditkasse | Finance |
| Inovio AS | Health Technology |
Affitech AS /Old/
Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Affitech AS discovers and develops human therapeutic antibodies. It focuses on molecule and cell based antibody discovery. The company was founded by Martin Welschof, Ole Jorgen Marvik, and Michael Braunagel in 1997 and is headquartered in Oslo, Norway. | Commercial Services |
Nextera AS
Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Commercial Services |
Otivio AS
Otivio AS Medical SpecialtiesHealth Technology Otivio AS manufactures non-invasive medical devices. The private company is based in Oslo, Norway. | Health Technology |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
RespiNor AS
RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Electronic Technology |
- Borsa valori
- Insiders
- Hans Petter Tjeldflaat